9
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Facilitation of Spike-Wave Activity by the Hypnotic Etomidate in a Rat Model for Absence Epilepsy

, , , &
Pages 213-217 | Received 06 Jul 1990, Published online: 07 Jul 2009

References

  • Baiker-Heberlein M., Kenins P., Kikillus H., Meinck H. M., Schomburg E. D. Investigations on the site of the central nervous action of the short-acting hypnotic agent r-(+)-ethyl-1-(alpha-methyl-benzyl) imidazole-5-carboxylate (etomidate) in cats. Anaesthesist 1979; 28: 78–84
  • Coenen A. M. L., Van Luijtelaar E. L. J. M. The WAG/Rij rat model for absence epilepsy: age and sex factors. Epilepsy Research 1987; 1: 297–301
  • Doenicke A., Kugler J., Penzel G., Laub M., Killian J., Kalmar L., Bezecny H. Hirnfunktion und Toleranzbreite nach Etomidate, einem neuen barbituratfreien i.v. applizierbaren Hypnotikum. Anaesthesist 1973; 22: 357–366
  • Doenicke A., Loeffler B., Kugler J., Suttman H., Grote B. Plasma concentration and E.E.G. after various regimens of etomidate. British Journal of Anaesthesia 1982; 54: 393–400
  • Ebrahim Z. Y., De Boer G. E., Luders H., Hahn J. F., Lesser R. P. Effect of etomidate on the electroencephalogram of patients with epilepsy. Anesthesiology and Analgesia 1986; 65: 1004–1006
  • Evans R. H., Gill R. G. GABA mimetic action of etomidate. Experientia 1978; 34: 1325–1327
  • Gancher S., Laxer K. D., Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology 1984; 61: 616–618
  • Grant I. S., Hutchison G. Epileptiform seizures during prolonged etomidate sedation. Lancet 1983; 2: 511–512
  • Inoue M., Peeters B. W. M. M., Van Luijtelaar E. L. J. M., Coenen A. M. L. Spontaneous occurrence of spike-wave discharges in five inbred strains of rats. Physiology and Behavior 1990; 48: 199–208
  • Löscher W. Comparative assay of anticonvulsant and toxic potencies of sixteen GABA-mimetic drugs. Neuropharmacology 1982; 21: 803–810
  • Marescaux C., Micheletti G., Vergnes M., Depaulis A., Rumbach L., Warter J. M. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia 1984; 25: 326–331
  • Matthews W. D., McCafferty G. P. Anticonvulsant activity of muscimol against seizures induced by impairment of GABA-mediated neurotransmission. Neuropharmacology 1979; 18: 885–889
  • Micheletti G., Vergnes M., Marescaux C., Reis J., Depaulis A., Rumbach I., Warter J. M. Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat. Arzneimittel-Forschung Drug Research 1985; 35: 483–485
  • Peeters B. W. M. M., Spooren W. P. J. M., Van Luijtelaar E. L. J. M., Coenen A. M. L. The WAG/Rij rat model for absence epilepsy: anticonvulsant drug evaluation. Neuroscience Research Communications 1988; 2: 93–97
  • Peeters B. W. M. M., Van Rijn C. M., Vossen J. M. H., Coenen A. M. L. Effects of GABA-ergic agents on spontaneous non-convulsive epilepsy. EEG and behaviour, in the WAG/Rij inbred strain of rats. Life Sciences 1989; 45: 1171–1176
  • Van Luijtelaar E. L. J. M., Coenen A. M. L. Two types of electrocortical paroxysms in an inbred strain of rats. Neuroscience Letters 1986; 70: 393–397
  • Wauquier A. Profile of etomidate. A hypnotic, anticonvulsant and brain protective compound. Anaesthesia 1983; 38S: 26–33
  • Wauquier A., Ashton D., Clincke G., Niemegeers C. J. E., Janssen P. A. J. Etomidate: ein barbituratfreies Hypnotikum antikonvulsive, antinoxische und hirnprotektive Wirkung in Tierexperiment. Anasthesie bei zerebralen Krampfanfallen und Intensivtherapie des Status epilepticus, A Opitz, R Degen. Verlagsgesellschafl, Erlangen 1980; 183–203
  • Wauquier A., Van den Broeck W. A., Verheyen J. L., Janssen P. A. J. Electroencephalographic study of the short-acting hypnotics etomidate and methohexital in dogs. European Journal of Pharmacology 1978; 47: 367–377
  • Worms P., Depoortere H., Lloyd K. G. Neuropharmacological spectrum of muscimol. Life Sciences 1979; 25: 607–614

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.